A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

NCT07180862 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: BAT3306
DRUG: US-Keytruda®

Sponsor

Bio-Thera Solutions